CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $351 | +20.6% | 12,876 | -1.7% | 0.02% | +36.4% |
| Q2 2023 | $291 | -24.6% | 13,099 | -26.6% | 0.01% | -31.2% |
| Q1 2023 | $386 | +6.0% | 17,842 | -0.3% | 0.02% | 0.0% |
| Q4 2022 | $364 | -99.9% | 17,904 | -17.2% | 0.02% | -27.3% |
| Q3 2022 | $555,000 | -14.5% | 21,636 | -20.8% | 0.02% | +15.8% |
| Q2 2022 | $649,000 | +5.7% | 27,304 | +0.2% | 0.02% | +35.7% |
| Q1 2022 | $614,000 | -0.8% | 27,256 | -12.9% | 0.01% | +7.7% |
| Q4 2021 | $619,000 | +1.0% | 31,287 | +0.5% | 0.01% | -7.1% |
| Q3 2021 | $613,000 | -14.1% | 31,137 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $714,000 | +23.1% | 32,477 | +33.3% | 0.01% | +16.7% |
| Q1 2021 | $580,000 | -9.5% | 24,371 | -0.6% | 0.01% | -7.7% |
| Q4 2020 | $641,000 | +50.1% | 24,511 | 0.0% | 0.01% | +30.0% |
| Q3 2020 | $427,000 | +3.6% | 24,511 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $412,000 | – | 24,511 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |